Jamjoom Pharmaceuticals Factory Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA15QGU1UNH6
SAR
137.50
-3.3 (-2.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jamjoom Pharmaceuticals Factory Co.
Why is Jamjoom Pharmaceuticals Factory Co. ?
1
With ROE of 26.14%, it has a very attractive valuation with a 6.71 Price to Book Value
  • Over the past year, while the stock has generated a return of -13.08%, its profits have risen by 23% ; the PEG ratio of the company is 1.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Jamjoom Pharmaceuticals Factory Co. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jamjoom Pharmaceuticals Factory Co. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Jamjoom Pharmaceuticals Factory Co.
-12.64%
0.04
30.67%
Saudi Arabia All Share TASI
-12.63%
-0.89
14.47%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.44%
EBIT Growth (5y)
16.61%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.85
Tax Ratio
5.60%
Dividend Payout Ratio
60.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.93%
ROE (avg)
21.80%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
6.71
EV to EBIT
25.22
EV to EBITDA
23.07
EV to Capital Employed
7.41
EV to Sales
7.70
PEG Ratio
1.12
Dividend Yield
NA
ROCE (Latest)
29.37%
ROE (Latest)
26.14%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
ROCE(HY)

Highest at 27.7%

DIVIDEND PAYOUT RATIO(Y)

Highest at 106.04%

RAW MATERIAL COST(Y)

Fallen by -0.31% (YoY

DIVIDEND PER SHARE(HY)

Highest at SAR 2.02

-3What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 47,610.12

DEBT-EQUITY RATIO (HY)

Highest at -10.69 %

Here's what is working for Jamjoom Pharmaceuticals Factory Co.
Dividend per share
Highest at SAR 2.02
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (SAR)

Dividend Payout Ratio
Highest at 106.04%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -0.31% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at SAR 10.59 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (SAR MM)

Here's what is not working for Jamjoom Pharmaceuticals Factory Co.
Interest Coverage Ratio
Lowest at 47,610.12
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio
Highest at -10.69 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio